0001595971-16-000001.txt : 20160202 0001595971-16-000001.hdr.sgml : 20160202 20160202155516 ACCESSION NUMBER: 0001595971-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160202 DATE AS OF CHANGE: 20160202 EFFECTIVENESS DATE: 20160202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Agilis Biotherapeutics, LLC CENTRAL INDEX KEY: 0001595971 IRS NUMBER: 463936833 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-256536 FILM NUMBER: 161380792 BUSINESS ADDRESS: STREET 1: 5956 SHERRY LANE STREET 2: SUITE 1810 CITY: DALLAS STATE: TX ZIP: 75225 BUSINESS PHONE: (214)706-4340 MAIL ADDRESS: STREET 1: 5956 SHERRY LANE STREET 2: SUITE 1810 CITY: DALLAS STATE: TX ZIP: 75225 D 1 primary_doc.xml X0707 D LIVE 0001595971 Agilis Biotherapeutics, LLC 245 First St. Suite 1800 Cambridge MA MASSACHUSETTS 02142 (617)-444-8706 DELAWARE None None Limited Liability Company true 2013 G. Houston Hall 245 First St. Suite 1800 Cambridge MA MASSACHUSETTS 02142 Director Manager of the Issuer Alexander M. Seaver 245 First St. Suite 1800 Cambridge MA MASSACHUSETTS 02142 Director Manager of the Issuer Adrian Z. Stecyk 245 First St. Suite 1800 Cambridge MA MASSACHUSETTS 02142 Director Manager of the Issuer Mark J. Pykett 245 First St. Suite 1800 Cambridge MA MASSACHUSETTS 02142 Director Manager of the Issuer Arthur Tzianabos 245 First St. Suite 1800 Cambridge MA MASSACHUSETTS 02142 Director Manager of the Issuer Biotechnology Decline to Disclose 06b false true false true true false 0 5000000 0 5000000 false 0 0 0 0 false Agilis Biotherapeutics, LLC Mark Pykett Mark Pykett Manager of the Issuer 2016-01-25